We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

MRI Technique for Detecting Cancer Could Replace Biopsies

By MedImaging International staff writers
Posted on 06 Apr 2015
A study suggests Magnetic Resonance Imaging (MRI) could be used for the noninvasive detection of cancer cells to complement or replace biopsies, without the need for injection of contrast dyes.

Researchers at Johns Hopkins School of Medicine (Baltimore, MD, USA) tested a technique that detects sugar molecules shed by the outer membranes of cancerous cells, so far only on lab-grown cells and mice.

Image: Normal cells (left) have far more sugar attached to mucin proteins than do cancerous cells (right). Mucin-attached sugar generates a high MRI signal, shown in red (Photo courtesy of Xiaolei Song/Johns Hopkins Medicine).
Image: Normal cells (left) have far more sugar attached to mucin proteins than do cancerous cells (right). Mucin-attached sugar generates a high MRI signal, shown in red (Photo courtesy of Xiaolei Song/Johns Hopkins Medicine).

The results of the study were published on online, in the journal Nature Communications on March 27, 2015.

Xiaolei Song, PhD, the lead author on the study, said, “This is the first time a property integral to cancer cells, rather than an injected dye, has been used to detect those cells. The advantage of detecting a molecule already inside the body is that we can potentially image the entire tumor. This often isn’t possible with injected dyes because they only reach part of the tumor. Plus, the dyes are expensive.

The team will next try to distinguish additional types of cancerous tumors from benign masses in live mice. If they succeed it could lead to earlier detection of cancer, new methods to monitor response to chemotherapy, and new ways to guide biopsies that may eventually make some biopsies unnecessary.

Related Links:

Johns Hopkins School of Medicine



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
Ultrasound System
Acclarix AX9

Latest MRI News

World's First Whole-Body Ultra-High Field MRI Officially Comes To Market

World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans